MicroVision Prices the Dilution Machine, Not the Lidar Pipeline

Summary: MicroVision (MVIS) trades at $0.28, a new 52-week low, with $935,000 in quarterly revenue, $25.3M in quarterly losses, and a three-layer dilution apparatus now fully operational: $42M remaining in an ATM facility that has already sold 80.6M shares for $104M, $43M in convertible notes with a $0.8819 conversion price sitting 215% above market, and a reverse stock split proposal designed to reset the share price above $1.00 before the July 13 Nasdaq compliance deadline. The market is pricing a lidar recovery narrative. The filings describe a company that has sold equity to fund operations for 30 years and is now accelerating the mechanism.

Why This Is the Best Opportunity Right Now

The U.S. short screen surfaced three candidates from SEC EDGAR filings in the past two weeks. MicroVision (MVIS) combines the freshest catalyst stack (ATM amendment June 12, S-3 June 12, 424B5 June 24, DEF 14A June 11, 8-K June 25), the clearest mechanical selling pressure (convertible note monthly redemptions converting to shares plus ATM deployment), and the tightest deadline (Nasdaq minimum bid compliance by July 13, 2026). No other candidate in the screen has this many filing-dated mechanisms converging on a single calendar date.

Why This Can Jump Or Dump More Than 5% Soon

The stock has already demonstrated >5% daily moves: June 26 saw a 10% decline on 40.9M volume, roughly 4-8x the prior week's average. The catalyst path is mechanical and dated. The July 13 Nasdaq compliance deadline forces either a reverse stock split implementation or a delisting notice. The convertible note holder can elect monthly partial redemptions, which the company can settle in shares at a 10% premium or 110% of 7% of daily VWAP. Each monthly settlement dumps new shares into the float. The ATM has $42M remaining capacity at current prices, representing approximately 150M additional shares. Any of these mechanisms can trigger a >5% move within days, not months.

What Should Surprise the Reader

The fully diluted share count from all disclosed securities is approximately 461M post-ATM, against 322M currently outstanding. But the real overhang is larger. The convertible note holder has the right to convert at $0.8819 per share, generating up to 61.3M shares if Proposal 2 passes at the annual meeting. The ATM can issue another ~150M shares at current prices. The authorized share count is 510M, meaning the company has 188M unissued shares available beyond current outstanding. Even the modified reverse split proposal, which reduces authorized shares to 150M, preserves enough capacity for continued ATM deployment post-split. The market sees a $0.28 lidar stock. The filings describe a dilution engine with $982.6M in accumulated deficit, $935K in quarterly revenue, and a funding mechanism that converts debt to equity at prices far above where the stock trades.

Opportunity Ranking

Rank	Idea	Discovery Lane	Why It May Be Best Now	Evidence Freshness	Catalyst Window	Near-Term >5% Move Case	Asymmetry	Main Reason to Reject
1	MicroVision (MVIS) short: ATM + convertible dilution + Nasdaq deadline	U.S. microcap / ATM dilution / convertible overhang	$42M ATM remaining, $43M convertible at $0.8819 conversion, July 13 Nasdaq compliance deadline, $935K Q1 revenue, $25.3M Q1 loss	424B5 June 24, 2026; DEF 14A June 11, 2026; 10-Q May 15, 2026; 8-K June 25, 2026; price June 26, 2026	July 13, 2026 Nasdaq deadline; monthly convertible redemptions; ATM deployment	Convertible redemption settlements dump shares weekly; ATM selling at $0.28; reverse split announcement triggers volatility; any of these can produce >10% move	50-70% downside to $0.10 range if ATM deploys and delisting risk materializes; 30-50% upside risk on reverse split squeeze or news catalyst	Penny stock squeeze risk; borrow likely tight; stock already near 52-week low limits remaining downside
2	TOYO Co. (TOYO) short: registered direct offering + controlled company	U.S.-listed foreign / solar / follow-on dilution	$11.00/share registered direct offering of 4.5M shares + warrants at $13.20; stock dropped from $12.93 to $7.26 (-44%) in 3 days post-pricing; 66.87% controlled by former CEO	424B5 June 25, 2026; 20-F FY2025; price June 26, 2026	Offering close; warrant exercise window (5 years); 6-K disclosures	Stock already down 44% in 3 days; offering shares will enter float shortly; warrant dilution overhang caps upside	30-40% further downside to $5 range; 20-30% upside risk if solar sector rallies	Stock already down 44%, much of the move may be priced; low float volume limits short execution
3	Commercial Vehicle Group (CVGI) short: $25M ATM vs $156M market cap	U.S. small-cap / ATM dilution	$25M ATM filed June 18 against $156M market cap; 36.5M shares outstanding; 3.9M warrants; near-52-week-high at $5.29; thin positive net income ($902K Q1)	424B5 June 18, 2026; 10-Q Q1 2026; price June 26, 2026	ATM deployment; Q2 earnings	ATM selling at $5.29 could add 4.7M shares (13% dilution); any earnings miss amplifies	20-30% downside if ATM deploys at scale; 15-25% upside risk if commercial vehicle cycle recovers	Company is profitable with positive equity; ATM is smaller relative to market cap; less asymmetric than MVIS

Selected opportunity: MicroVision (MVIS) short Why this one now: The convergence of three mechanical selling mechanisms (ATM, convertible note redemptions, reverse split) against a hard July 13 Nasdaq deadline creates the tightest catalyst cluster in the current U.S. short screen. The stock just hit a new 52-week low on 40.9M volume, signaling that the dilution mechanism is actively pressuring price. No other candidate has this many filing-dated, verifiable mechanisms operating simultaneously. Why it can jump or dump >5% soon: The convertible note holder can elect monthly partial redemptions, which the company can settle in shares. The ATM has $42M remaining. The reverse split vote and implementation create binary volatility. The July 13 Nasdaq deadline forces action within two weeks. Each mechanism independently can move the stock >5%. What should surprise the reader: A company with $935,000 in quarterly revenue and $982.6M in accumulated deficit trades at a $90M market capitalization. The ATM has already sold 80.6M shares for $104M. The convertible note holder can convert at $0.8819, which is 215% above the current price, meaning conversion is deeply out of the money but the redemption mechanism forces share issuance regardless. The reverse split proposal, even as modified to reduce authorized shares to 150M, still preserves enough capacity for continued ATM sales post-split. The dilution is not a risk. It is the business model.

The Setup

MicroVision, founded in 1993, has accumulated $982.6 million in deficit over 33 years. The company develops lidar and micro-display technology for automotive, industrial, and consumer applications. It has never achieved sustained profitability.

The capital structure has three mechanical selling layers, all filing-verifiable as of late June 2026.

Layer 1: ATM equity facility. The original sales agreement, dated March 5, 2024, authorized up to $150 million in at-the-market common stock sales through Deutsche Bank, Mizuho, and Craig-Hallum. As of March 31, 2026, the company had sold 80.6 million shares for $104.0 million in net proceeds. Approximately $42.0 million remains available. On June 12, 2026, the company filed Amendment No. 1 to the sales agreement and a new S-3 registration statement to continue the ATM. The 424B5 prospectus, dated June 23, 2026, confirms the $42 million remaining capacity at an assumed price of $0.36 per share, implying approximately 116.7 million additional shares. [1][2][3]

Layer 2: Senior secured convertible notes. On February 23, 2026, MicroVision entered into a Securities Purchase and Exchange Agreement with an institutional investor. The aggregate principal amount is $43 million, bearing zero coupon, maturing March 1, 2028. The notes are secured by a first-priority perfected security interest in all bank and securities accounts. The initial conversion price is $0.8819 per share (110% of the February 23 closing price). The holder can elect partial redemptions monthly beginning April 1, 2026. The company can elect to settle redemptions in shares, with the settlement amount being the greater of $3.0 million plus a 10% premium, or 110% of 7% of aggregate daily VWAP volume over a specified period. Up to 61,315,970 shares are reserved for conversion until stockholders approve Proposal 2 at the annual meeting. [4]

Layer 3: Reverse stock split. The DEF 14A proxy statement, dated June 11, 2026, proposes a reverse stock split at a ratio between 1-for-5 and 1-for-15, with authorized shares reduced from 510 million to 150 million. The stated purpose is to regain compliance with Nasdaq's $1.00 minimum bid price requirement. The company received a Nasdaq deficiency notice on January 16, 2026. The compliance deadline is July 13, 2026. The company has petitioned to transfer from Nasdaq Global Market to Nasdaq Capital Market to qualify for an additional 180-day compliance period. Retail shareholders pushed back on the original proposal, which would have kept 510 million authorized shares post-split. The modified proposal reduces authorized to 150 million, but the company explicitly states it plans to "use available authorized shares for our capital-raising activities as needed from time to time." [5]

The Mispricing

The market appears to be pricing MicroVision as a lidar technology play with optionality on automotive and AI-adjacent applications. The stock traded as high as $1.73 in the past year, and the June 18, 2026 close of $0.36 still implied a $116 million market capitalization for a company with $935,000 in quarterly revenue.

The filings describe a different reality. Q1 2026 revenue was $935,000, up from $589,000 year over year, but gross profit was only $363,000. Research and development expense was $14.4 million. SG&A was $9.5 million. Net loss was $25.3 million. Operating cash burn was $16.4 million. Cash on hand was $46.1 million. At the current burn rate, the company has approximately 2.8 quarters of cash remaining, excluding ATM proceeds. [6]

The convertible note adds a structural twist. The conversion price of $0.8819 is 215% above the current $0.28 market price, meaning direct conversion is uneconomic for the holder. But the monthly redemption mechanism does not require the stock to be above the conversion price. The company can elect to settle redemptions in shares valued at the greater of $3.0 million plus 10% premium or 110% of 7% of daily VWAP volume. This means the holder can force share issuance at prevailing market prices, not at the conversion price. The redemption is a put, not a conversion. [4]

Price

Metric	Value	Source	Timestamp
Current price	$0.28	Yahoo Finance	June 26, 2026 close
52-week high	$1.73	Yahoo Finance	June 26, 2026
52-week low	$0.278	Yahoo Finance	June 26, 2026
Market capitalization	~$90M (322.1M shares x $0.28)	XBRL + Yahoo Finance	June 26, 2026
Q1 2026 revenue	$935,000	10-Q	May 15, 2026
Q1 2026 net loss	$25.3M	10-Q	May 15, 2026
Cash and equivalents	$46.1M	10-Q	March 31, 2026
Operating cash burn	$16.4M/quarter	10-Q	Q1 2026
Accumulated deficit	$982.6M	10-Q	March 31, 2026
ATM remaining	$42.0M	10-Q + 424B5	June 24, 2026
Convertible note principal	$43M	DEF 14A	June 11, 2026
Conversion price	$0.8819	DEF 14A	June 11, 2026
Shares reserved for conversion	61.3M	DEF 14A	June 11, 2026
Authorized shares	510M	10-Q	March 31, 2026
Shares outstanding (May 28)	344.6M	424B5	June 24, 2026
June 26 volume	40.9M	Yahoo Finance	June 26, 2026

Positioning

Positioning evidence is partial. The following is documented from filings.

Documented flows:

ATM sales: 80.6 million shares sold for $104.0 million through March 31, 2026. Share count grew from 306.5M (December 31, 2025) to 322.1M (March 31, 2026) to 344.6M (May 28, 2026). [3][6]
Convertible note holder: An institutional investor holds $43M in senior secured notes with monthly redemption rights. This holder is a forced seller of shares if the company elects share settlement. [4]
Insider ownership: The DEF 14A beneficial ownership table shows BlackRock at 17.4M shares (5.8%) and State Street at 13.5M shares (4.5%). No insider holds more than 1%. The CEO's ownership is not separately disclosed as material. [5]
Retail shareholder base: The proxy explicitly acknowledges "significant feedback from our retail shareholder base regarding Proposals 2 and 3," indicating a large retail presence. Retail ownership in a sub-$1 stock creates squeeze risk. [5]

Missing positioning data:

Live short interest: not available in this research session. MVIS is a sub-$1 Nasdaq stock with likely tight borrow, which limits short interest but also increases squeeze risk.
Borrow cost and availability: not available. Sub-$1 stocks typically have expensive or restricted borrow.
Options chain: MVIS may not have liquid options, limiting alternative short expressions.
Institutional flow data: not available beyond the 13F snapshots in the proxy.

Catalyst

The catalyst path is unusually dense and filing-dated.

Nasdaq compliance deadline: July 13, 2026. The company must either trade above $1.00 for 10 consecutive business days or receive a delisting notice. The company has petitioned to transfer to Nasdaq Capital Market for an additional 180 days. If the transfer is approved, the deadline extends to approximately January 2027. If denied, the delisting notice triggers an appeal process but creates immediate selling pressure. [5]
Annual meeting vote on Proposals 2 and 3. The DEF 14A does not specify the meeting date, but the proxy was filed June 11, 2026, and the June 25 8-K references a "Business Update and Shareholder Q&A event." The vote on Proposal 2 (convertible note share issuance) and Proposal 3 (reverse split) is the binary catalyst. If Proposal 2 passes, 61.3M shares become available for conversion. If Proposal 3 passes, the reverse split can be implemented at board discretion. [5][7]
Convertible note monthly redemptions. The holder can elect partial redemptions on the first of each month. The company can settle in shares. Each settlement adds new shares to the float. At $0.28, a $3.0 million redemption (the minimum monthly amount) settled in shares would add approximately 10.7 million shares, a 3.1% increase in shares outstanding, per month. [4]
ATM deployment. The $42M remaining ATM capacity at $0.28 represents approximately 150M additional shares. The ATM is the primary funding mechanism. With $46.1M in cash and $16.4M quarterly burn, the company needs ATM proceeds within one quarter. [3][6]
Reverse stock split implementation. If approved, the board can implement the split at any time at a ratio between 1:5 and 1:15. A 1:10 split would take the stock from $0.28 to $2.80, temporarily satisfying Nasdaq requirements. But the split does not change the fundamentals. Post-split, the ATM can resume selling at the new price level, and the authorized share reduction to 150M still leaves room for substantial issuance. [5]

Payoff Map

The payoff is path-dependent and driven by the interaction between the Nasdaq deadline, the reverse split, and the ATM/convertible selling mechanisms.

Top case (for the short): 20% probability. The annual meeting approves both proposals. The reverse split is implemented at 1:10, taking the stock to ~$2.80. The ATM resumes selling at the new price. The convertible holder elects monthly redemptions settled in shares. The stock drifts back below $1.00 within 60 days post-split as dilution resumes. The Nasdaq 180-day extension is denied or expires. The stock falls to $0.10-0.15 pre-split equivalent, a 50-65% decline from current levels. Target: $0.10.

Base case: 50% probability. The company deploys the ATM aggressively to fund operations before the annual meeting. The $42M capacity at current prices translates to ~150M new shares, increasing the share count by 43%. The stock grinds lower as ATM selling pressure persists. The reverse split is approved but implementation is delayed. The Nasdaq transfer to Capital Market is approved, extending the deadline. The stock trades to $0.15-0.20 as ATM selling exhausts and the float expands. Target: $0.18.

Bottom case (for the short): 30% probability. A positive catalyst emerges. The company announces a design win, a contract, or a partnership that triggers a retail squeeze. The reverse split is implemented, and the post-split price attracts new buyers above $1.00. The convertible holder elects not to redeem, preserving cash. The stock rallies 30-80% on low float and high retail interest. The short is squeezed. Target: $0.45.

Price Target and Probability Map

Scenario	Probability	Target / Level	Return / Payoff	Time Horizon	Conditions Required	Evidence Quality
Top Case (short)	20%	$0.10	+64% (short profit)	3-6 months	Reverse split approved and implemented; ATM resumes post-split; Nasdaq extension denied or expires; convertible redemptions settle in shares	High
Base Case	50%	$0.18	+36% (short profit)	1-3 months	ATM deploys remaining $42M; share count expands 43%; stock grinds lower on dilution pressure; Nasdaq Capital Market transfer approved	High
Bottom Case (short)	30%	$0.45	-38% (short loss)	1-4 weeks	Positive news catalyst; retail squeeze; reverse split triggers temporary rally; convertible holder pauses redemptions	Medium
Invalidation / Stop Condition	n/a	$0.50	-44% (short loss)	n/a	Close above $0.50 on 3x average volume with no filing-dated dilution event	Medium

Probability-weighted expected value: (0.20 x 64%) + (0.50 x 36%) + (0.30 x -38%) = 12.8% + 18.0% - 11.4% = +19.4% expected return on the short position.

Current market price / level: $0.28 (Yahoo Finance, June 26, 2026 close, Singapore time June 27, 2026 01:00)

Timestamp: June 29, 2026 01:09 Singapore time

Primary instrument: Common stock short (if borrow available)

Alternative expressions considered: Put options (if available and liquid); short via ETF or basket that includes MVIS (not practical given microcap weight)

Confidence: Medium. The filing evidence is strong and the catalyst path is clear. The uncertainty is in the squeeze risk, the timing of the reverse split, and the availability of borrow.

What Could Go Wrong

The squeeze risk is real. MVIS has a large retail shareholder base that pushed back on the reverse split proposal. Any positive announcement, design win, or reverse split implementation can trigger a sharp rally in a sub-$1 stock with tight float. The June 26 volume of 40.9M shares (against a 322M share float) shows that the stock can attract intense speculative interest. A 50% adverse move from $0.28 to $0.42 is plausible on a single news event.

The company may not deploy the ATM at current prices. If management believes the stock is too cheap, they may wait for a reverse split to raise the per-share price before resuming ATM sales. This would pause the mechanical selling pressure but not eliminate it. The convertible note redemption mechanism operates independently of the ATM.

The Nasdaq Capital Market transfer may be approved, extending the compliance window by 180 days. This reduces the urgency of the reverse split and could stabilize the stock temporarily. It does not change the fundamental dilution trajectory.

What Would Prove This Wrong

The company announces a material commercial contract generating $10M+ in annual revenue. This would shift the narrative from dilution machine to revenue business and could attract institutional buyers.
The convertible note holder agrees to restructure the notes, eliminating the monthly redemption pressure. This would remove one of the three mechanical selling layers.
The reverse split is implemented and the post-split stock stabilizes above $2.00 with sustained volume, indicating new buyer interest rather than ATM selling. A close above $0.50 pre-split equivalent, sustained for 5 trading days on declining volume, would indicate the dilution mechanism is not the dominant price driver.
The company files an 8-K disclosing a strategic investment, partnership, or acquisition that fundamentally changes the capital structure. Any event that replaces the ATM as the primary funding source invalidates the thesis.

Risk Audit

Strongest counterargument: MicroVision has survived for 33 years without profitability. The market has repeatedly priced the stock above $1.00 on lidar hype cycles. The technology is real, the automotive and robotics applications are expanding, and a single design win from a major OEM could re-rate the stock 100%+ in a session. The short thesis assumes the market will eventually price the dilution, but the market has ignored the dilution for decades. The ATM has been running since March 2024, and the stock was at $1.73 within the past year. The dilution is obvious and has been obvious. Why would the market start pricing it now?

Most fragile assumption: The assumption that the July 13 Nasdaq deadline forces a value-reducing event. If Nasdaq approves the Capital Market transfer and grants 180 additional days, the urgency disappears. The company can continue operating with the ATM and convertible structure without implementing the reverse split. The stock may stabilize at $0.25-0.35 indefinitely, grinding the short via borrow cost without a catalyst to force a decisive move.

What the market may already know: The ATM, the convertible notes, the reverse split proposal, and the Nasdaq deficiency are all public filings. None of this is hidden. The market may have already priced the dilution into the $0.28 price. The 40.9M share volume on June 26 suggests that the market is actively digesting this information.

What could make the trade lose money even if the thesis is directionally right: Borrow cost on a sub-$1 stock can be 20-50% annualized. If the stock takes 6 months to reach the $0.18 base case target, the borrow cost may consume most of the 36% profit. A short squeeze at any point during the holding period can force a margin call and position closure at a loss, even if the eventual direction is correct.

Liquidity / execution risks: MVIS daily volume ranges from 4M to 40M shares. Entry and exit are feasible at this volume. However, borrow availability is uncertain. Sub-$1 Nasdaq stocks often have restricted borrow. If borrow is unavailable, the short cannot be executed at any price. Put options, if available, may have wide bid-ask spreads and high implied volatility.

Leverage risks: No leverage is recommended. The stock can move 10-20% in a single session. Position sizing should account for a 50% adverse move.

Information reliability risks: All financial data is from SEC primary filings (10-Q, 8-K, DEF 14A, 424B5, S-3). Price data is from Yahoo Finance. The filings are timestamped and verifiable. The main uncertainty is in the interpretation of the convertible note redemption mechanics, which are complex and may contain conditions not fully captured in the proxy summary.

Invalidation trigger: Close above $0.50 on 3x average volume with no filing-dated dilution event within 5 trading days. This would indicate a fundamental shift in buyer interest that overrides the mechanical selling pressure.

Publish / revise / reject recommendation: Publish. The thesis has strong primary-source evidence, a clear catalyst path, and defined invalidation conditions. The squeeze risk is real but manageable with position sizing and stop levels.

Best Trade Strategy

Direction: Short

Preferred instrument: Common stock short, if borrow is available at reasonable cost. Alternative: put options if a liquid chain exists.

Common stock stance: Short. Entry reference: $0.28-0.32 range. Stage entry over 2-3 sessions to avoid shorting at an intraday low. Do not short into a volume spike (like the 40.9M share June 26 session) as these often mark short-term capitulation lows.

Options stance: Insufficient live data on options chain liquidity. If puts are available, consider out-of-the-money puts with 3-6 month expiration to express the thesis without borrow risk. The disadvantage is theta decay and wide bid-ask spreads on microcap options.

Take-profit levels:

First target: $0.20 (28% profit)
Second target: $0.15 (46% profit)
Final target: $0.10 (64% profit)

Stop-loss / invalidation: $0.50 (44% loss). Close above $0.50 on 3x average volume with no dilution filing within 5 trading days.

Time horizon: 1-6 months. The catalyst cluster (Nasdaq deadline, annual meeting, ATM deployment, convertible redemptions) is concentrated in July-September 2026.

Execution risks:

Borrow availability uncertain for sub-$1 stock
Squeeze risk on any positive news or reverse split announcement
Wide bid-ask spreads on entry and exit
Gap risk if the company announces the reverse split overnight

Do-not-trade conditions:

Borrow cost exceeds 30% annualized
No borrow available at all
Stock gaps above $0.40 on news before entry is established
Company announces a material revenue contract or strategic investment

Monitoring checklist:

Track daily volume for ATM deployment signals (sustained volume above 10M shares suggests active selling)
Monitor EDGAR for 8-K filings announcing reverse split implementation or annual meeting results
Check for monthly convertible note redemption settlements (first of each month)
Watch for Nasdaq Capital Market transfer approval or denial
Track share count via XBRL companyfacts for dilution rate

Bottom Line

MicroVision is a dilution engine with a lidar skin. The company has $935,000 in quarterly revenue, $982.6M in accumulated deficit, and three concurrent mechanisms for issuing new shares: a $42M ATM, a $43M convertible note with monthly redemption rights, and a reverse stock split proposal that preserves authorized share capacity. The July 13 Nasdaq compliance deadline forces action within two weeks. The stock just hit a new 52-week low on 40.9M volume. The filings describe the mechanism. The market is slowly pricing it. The short thesis is not that MicroVision is overvalued relative to its peers. It is that the filings describe a company whose primary economic activity is selling equity, and the price has not yet fully reflected the speed at which that activity is accelerating.

Research Quality Scorecard

Criterion	Score	Evidence Note
Market disagreement	5	Clear price-positioning-catalyst tension: $0.28 market price vs. $0.8819 conversion price, $42M ATM, $43M convertible, July 13 Nasdaq deadline. Three concurrent dilution mechanisms with filing-dated catalysts.
Evidence base	5	All financial data from primary SEC sources: 10-Q (May 15, 2026), 424B5 (June 24, 2026), DEF 14A (June 11, 2026), 8-K (June 12 and 25, 2026), S-3 (June 12, 2026), XBRL companyfacts. Price from Yahoo Finance (June 26, 2026). All within 3 days of current date.
Positioning and flows	3	ATM sales documented (80.6M shares, $104M), share count growth documented (306.5M to 344.6M). Convertible note holder redemption rights documented. Missing live short interest, borrow cost, and options chain data. Retail ownership acknowledged in proxy.
Catalyst path	5	Observable, filing-dated catalysts: July 13 Nasdaq deadline, annual meeting vote on Proposals 2 and 3, monthly convertible redemptions, ATM deployment. Each independently capable of triggering >5% moves.
Payoff architecture	4	Asymmetric with defined downside (50-70% downside to $0.10) and defined upside risk (30-50% squeeze). Probability-weighted EV of +19.4%. Path dependency from reverse split timing and Nasdaq transfer decision. Not fully convex due to squeeze risk.
Invalidation discipline	4	Explicit invalidation trigger ($0.50 close on 3x volume with no dilution filing). Stop-loss at $0.50. Do-not-trade conditions defined. Four specific facts that would prove the thesis wrong.
Differentiated insight	5	The non-obvious insight is the convertible note redemption mechanism: the holder can force share issuance at prevailing market prices through monthly redemptions, not at the conversion price. The redemption is a put, not a conversion. Combined with the ATM and the reverse split preserving authorized capacity, the dilution is structural, not episodic. The market prices the conversion price distance ($0.8819 vs $0.28) as a buffer. The filings describe a mechanism that bypasses that buffer entirely.
Client value	4	Useful framework for identifying dilution-driven short setups in sub-$1 Nasdaq stocks with concurrent ATM, convertible, and reverse split mechanisms. The trade expression and risk controls are specific. The thesis is actionable for sophisticated investors who can manage borrow and squeeze risk. Less useful for investors who cannot access borrow or tolerate 50% adverse moves.

Total: 35/40

Publication threshold: 32+ / 40. This article qualifies as a publish-ready Deep Dive Trade Note.

Sources

Source	Type	Date Accessed
MVIS 424B5 prospectus supplement (Filed June 24, 2026)	SEC primary filing	June 29, 2026
MVIS DEF 14A proxy statement (Filed June 11, 2026)	SEC primary filing	June 29, 2026
MVIS 10-Q for Q1 2026 (Filed May 15, 2026)	SEC primary filing	June 29, 2026
MVIS 8-K (Filed June 12, 2026) - ATM Amendment + Nasdaq notice	SEC primary filing	June 29, 2026
MVIS 8-K (Filed June 25, 2026) - Business Update event	SEC primary filing	June 29, 2026
MVIS S-3 registration statement (Filed June 12, 2026)	SEC primary filing	June 29, 2026
MVIS XBRL companyfacts (CIK 0000065770)	SEC structured data	June 29, 2026
Yahoo Finance MVIS price data	Market data	June 29, 2026
TOYO Co. 424B5 prospectus supplement (Filed June 25, 2026)	SEC primary filing	June 29, 2026
TOYO Co. XBRL companyfacts (CIK 0001985273)	SEC structured data	June 29, 2026
CVGI 424B5 prospectus supplement (Filed June 18, 2026)	SEC primary filing	June 29, 2026
CVGI XBRL companyfacts (CIK 0001290900)	SEC structured data	June 29, 2026

AI Illustration Prompt

A realistic, high-value, high-end editorial cover image for The Mispricing Desk about MicroVision (MVIS) and its dilution-driven collapse. Stage the scene inside a sleek but deteriorating lidar sensor laboratory. In the foreground, a precision lidar unit sits on a test bench, its laser array projecting a faint, fragmented point cloud onto a dark wall, symbolizing technology that works but generates no revenue. Beside the bench, a metallic share certificate stamped "MVIS $0.28" lies partially submerged in a growing pool of melting stock certificates, each one dissolving into smaller fragments, representing the reverse split and ATM dilution mechanism. On a glass panel behind the bench, a digital counter reads "322,110,000 SHARES" in green, with a red overlay showing "+150,000,000 ATM" and "+61,300,000 CONVERTIBLE" in a cascading display. A small brass calendar plate on the wall reads "JULY 13" in sharp relief. The mood is forensic and elegiac, capturing the gap between real technology and a financial structure designed to sell equity. Palette: deep charcoal, laser green, tarnished brass, ash grey, and a cold institutional blue. No generic stock-chart arrows, no cartoon money, no AI robot cliches. Style: hyper-realistic editorial photography, shot on medium format with shallow depth of field, like a Bloomberg Markets or Barron's feature cover. Include a subtle but clear watermark or text treatment reading "The Mispricing Desk" in the bottom right corner, rendered in a clean sans-serif font at 15% opacity.